SCHEMBL30406437

SCHEMBL30406437

CN(C)CCNC(=O)c1cc2c(C=O)c(O)ccc2o1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.51
GAA P10253 2/20 0.42
ALDH1A1 P00352 4/20 0.42
ALOX12 P18054 2/20 0.42
HPGD P15428 1/20 0.42
KDM4E B2RXH2 3/20 0.41
HSD17B10 Q99714 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
TP53 P04637 2/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.39
POLB P06746 2/20 0.39
MAPT P10636 1/20 0.39
KDM4C Q9H3R0 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ACKR3 P25106 1/20 0.39
OPRM1 P35372 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2555270 1.00 CYP2D6 (0.51) CYP2D6GAAALDH1A1ALOX12HPGD
SCHEMBL22840642 0.87 CYP2D6 (0.43) CYP2D6MEN1KMT2APOLBSMN1; SMN2
SCHEMBL22840696 0.87 KDM4E (0.46) GAAALDH1A1ALOX12KDM4EHSD17B10
SCHEMBL2570250 0.85 HPGD (0.43) CYP2D6GAAALDH1A1ALOX12HPGD
SCHEMBL2573383 0.84 MEN1 (0.43) GAAALDH1A1ALOX12KDM4EHSD17B10
SCHEMBL2568190 0.77 ERN1 (0.56) ALDH1A1HPGDKDM4EHSD17B10MEN1
SCHEMBL14930229 0.76 KDM4E (0.67) GAAALDH1A1ALOX12HPGDKDM4E
SCHEMBL26424849 0.75 ERN1 (0.54) ALDH1A1TP53LMNAHTTSMN1; SMN2
SCHEMBL2565847 0.74 HTR2C (0.55) ALDH1A1HPGDKDM4EHSD17B10POLB
SCHEMBL30406177 0.74 KDM4E (0.53) GAAALDH1A1HPGDKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110172051-B IRE-1 alpha inhibitors 复星弘创(苏州)医药科技有限公司 2023-03-07 CN disclosed